Union Minister for Health and Family Welfare Mansukh Mandaviya on Tuesday (20 July) said that the Hyderabad-based vaccine maker Bharat Biotech will be supplying 3.5 crore doses of Covaxin in August, reports Livemint.
Mandaviya also apprised the Rajya Sabha that the government was receiving 11-12 crore doses of Covishield from Pune-based Serum Institute of India (SII) per month.
He also informed the members of the Upper House that the Defence Research and Development Organisation (DRDO) has transferred the technology to produce 2DG drug to four pharma companies other than Hyderabad-based Dr Reddy's Laboratories.
The drug has been given emergency use authorization (EUA) as an adjunct therapy in moderate to severe COVID-19 patients. Mandaviya also informed the members that the complete clinical study report of Phase-III trials of DRDO's 2DG oral drug in moderate to severe patients is expected to be available by the end of August 2021.
Mandaviya made the statements while submitting the government's official reply on managing the pandemic.